Japan Bioventure Develops Blood Test To Determine Depression Levels
This article was originally published in PharmAsia News
Executive Summary
Human Metabolome Technologies, a new bioventure in Japan, is helping to develop a biomarker for determining levels of depression by testing for the ethanolamine phosphate compound.